Biodegradable Nanoparticles Composed Entirely of Safe Materials That Rapidly Penetrate Human Mucus

Overview

Journal Angew Chem Int Ed Engl

Specialty Chemistry

Date 2011 Mar 4

PMID 21370345

Citations 76

Authors

Ming Yang

Samuel K Lai

Ying-Ying Wang

Weixi Zhong

Christina Happe

Michael Zhang

Jie Fu

Justin Hanes

Affiliations

Soon will be listed here.

Citing Articles

Breath and Beyond: Advances in Nanomedicine for Oral and Intranasal Aerosol Drug Delivery.

Du S, Wen Z, Yu J, Meng Y, Liu Y, Xia X Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770584 PMC: 11677467. DOI: 10.3390/ph17121742.

Human Exposure to Microplastics and Its Associated Health Risks.

Sun A, Wang W Environ Health (Wash). 2024; 1(3):139-149.

PMID: 39473618 PMC: 11504042. DOI: 10.1021/envhealth.3c00053.

Status Quo in the Liposome-Based Therapeutic Strategies Against Glioblastoma: "Targeting the Tumor and Tumor Microenvironment".

Haseeb M, Khan I, Kartal Z, Mahfooz S, Hatiboglu M Int J Mol Sci. 2024; 25(20).

PMID: 39457052 PMC: 11509082. DOI: 10.3390/ijms252011271.

Liposomal Drug Delivery against Using Furazolidone and N-Acetyl Cysteine in Augmented Therapy.

Alam M, Paget T, Yussuf Moosa N, Alghurairy H, Elkordy A Pharmaceutics. 2024; 16(9).

PMID: 39339161 PMC: 11435436. DOI: 10.3390/pharmaceutics16091123.

A temperature-responsive dual-hormone foam nanoengine improves rectal absorptivity of insulin-pramlintide for diabetes treatment.

Feng S, Zhang Y, Hou C, Liu Y, Gao Y, Song Y Sci Adv. 2024; 10(35):eadn8695.

PMID: 39196940 PMC: 11352908. DOI: 10.1126/sciadv.adn8695.

References

Kumari A, Yadav S, Yadav S . Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 2009; 75(1):1-18. DOI: 10.1016/j.colsurfb.2009.09.001. View

Emanuele R . FLOCOR: a new anti-adhesive, rheologic agent. Expert Opin Investig Drugs. 2005; 7(7):1193-200. DOI: 10.1517/13543784.7.7.1193. View

Mohamed F, van der Walle C . Engineering biodegradable polyester particles with specific drug targeting and drug release properties. J Pharm Sci. 2007; 97(1):71-87. DOI: 10.1002/jps.21082. View

Lai S, Wang Y, Hanes J . Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev. 2009; 61(2):158-71. PMC: 2667119. DOI: 10.1016/j.addr.2008.11.002. View

Lai S, OHanlon D, Harrold S, Man S, Wang Y, Cone R . Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci U S A. 2007; 104(5):1482-7. PMC: 1785284. DOI: 10.1073/pnas.0608611104. View

Yeo Y, Park K . Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Arch Pharm Res. 2004; 27(1):1-12. DOI: 10.1007/BF02980037. View

Tamada J, Langer R . The development of polyanhydrides for drug delivery applications. J Biomater Sci Polym Ed. 1992; 3(4):315-53. DOI: 10.1163/156856292x00402. View

Rodeheaver G, Kurtz L, Kircher B, Edlich R . Pluronic F-68: a promising new skin wound cleanser. Ann Emerg Med. 1980; 9(11):572-6. DOI: 10.1016/s0196-0644(80)80228-9. View

Dumortier G, Grossiord J, Agnely F, Chaumeil J . A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res. 2006; 23(12):2709-28. DOI: 10.1007/s11095-006-9104-4. View

10.

Escobar-Chavez J, Lopez-Cervantes M, Naik A, Kalia Y, Quintanar-Guerrero D, Ganem-Quintanar A . Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharm Sci. 2007; 9(3):339-58. View

11.

Dawson M, Wirtz D, Hanes J . Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport. J Biol Chem. 2003; 278(50):50393-401. DOI: 10.1074/jbc.M309026200. View

12.

Lo J, Appel L, Herbig S, McCray S, Thombre A . Formulation design and pharmaceutical development of a novel controlled release form of azithromycin for single-dose therapy. Drug Dev Ind Pharm. 2009; 35(12):1522-9. DOI: 10.3109/03639040903037223. View

13.

Batrakova E, Kabanov A . Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release. 2008; 130(2):98-106. PMC: 2678942. DOI: 10.1016/j.jconrel.2008.04.013. View

14.

Putnam D . Polymers for gene delivery across length scales. Nat Mater. 2006; 5(6):439-51. DOI: 10.1038/nmat1645. View

15.

Suh J, Dawson M, Hanes J . Real-time multiple-particle tracking: applications to drug and gene delivery. Adv Drug Deliv Rev. 2004; 57(1):63-78. DOI: 10.1016/j.addr.2004.06.001. View

16.

Lai S, Wang Y, Wirtz D, Hanes J . Micro- and macrorheology of mucus. Adv Drug Deliv Rev. 2009; 61(2):86-100. PMC: 2736374. DOI: 10.1016/j.addr.2008.09.012. View

17.

Cone R . Barrier properties of mucus. Adv Drug Deliv Rev. 2009; 61(2):75-85. DOI: 10.1016/j.addr.2008.09.008. View

18.

Hoffman A . The origins and evolution of "controlled" drug delivery systems. J Control Release. 2008; 132(3):153-63. DOI: 10.1016/j.jconrel.2008.08.012. View

19.

Lai S, Wang Y, Hida K, Cone R, Hanes J . Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses. Proc Natl Acad Sci U S A. 2009; 107(2):598-603. PMC: 2818964. DOI: 10.1073/pnas.0911748107. View

20.

Pui C . Rasburicase: a potent uricolytic agent. Expert Opin Pharmacother. 2002; 3(4):433-42. DOI: 10.1517/14656566.3.4.433. View